CBER

CBER, or the Center for Biologics Evaluation and Research, is a division of the U.S. Food and Drug Administration (FDA). It is responsible for reviewing and monitoring biological products such as vaccines, blood products, gene therapies, and other medical treatments derived from living organisms. CBER ensures these products are safe, effective, and manufactured to high quality standards before they reach patients. Its work involves evaluating new products, overseeing their manufacturing, and monitoring their safety once they are on the market, helping to protect public health.